Searched for
TAKEDA
'Include me in layoff': Techie makes strange request even though she did not lose her job and instead got a 75% hikeA data scientist in Seattle resigned from her tech job after her company laid off 40 percent of its workforce. She felt survivor's guilt an...- Takeda deepens AI drug discovery push with $1.7 billion Iambic dealIambic and Takeda Pharmaceutical have formed a multi-year partnership valued at over $1.7 billion. This collaboration will leverage artific...
- Takeda to launch dengue vaccine in India next yearTakeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological ...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentTakeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurit...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Dr Reddy's inks licensing pact with Takeda to sell gastrointestinal drugNew Delhi: Dr Reddy's Laboratories, a Hyderabad-based firm, and Takeda Pharmaceutical entered a non-exclusive licensing pact to market 10mg...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- Takeda to soon start trials in India for dengue vaccineTakeda Pharmaceuticals' dengue vaccine assumes significance since the first vaccine ever licensed for dengue, developed by French drugmaker...
- Takeda, Biological E enter manufacturing pact to produce 50 million doses of Dengue vaccineJapanese drug giant Takeda has partnered with Indian vaccine maker Biological E (BE) to manufacture its Dengue vaccine. BE will increase it...
- Japan's Takeda signs MoU with BIRAC to support healthcare startupsJapanese drug maker Takeda on Tuesday entered into a three-year memorandum of understanding (MoU) with the Biotechnology Industry Research ...
- Takeda in talks to bring its dengue shot to IndiaIndia is not a part of the global Phase-3 trial of the Takeda dengue vaccine candidate, which means as per local regulation it will have to...
- Takeda India chief Aman Bajaaj resignsBajaaj will be replaced by Ashok Bhattacharya, the current head of commercial operations. A spokesperson for Takeda confirmed the top level...
- Wipro rallies over 3% on Rs 2,400 cr order win from Takeda PharmaWipro rallied 3%, after it won an over Rs 2,400 cr deal from Takeda Pharma under which the former will support IT requirements of the pharm...
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Tata group's Advinus Pharma ties up with Takeda Pharma for drug R&DAdvinus Pharma has entered into a joint drug discovery deal with Takeda Pharma, indicating interest of MNCs in Indian drug research.
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Japan's Takeda eyes Lupin, Cipla pharma businessTakeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...
- Ranbaxy settles drug dispute with Takeda, US launch in 2012Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...
- Japan's Takeda in $8.8 billion bid for US biotech firmJapan's Takeda Pharmaceutical Co has agreed to pay about $8.8 billion for US biotech company Millennium Pharmaceuticals Inc, the two firms ...
Load More
